This is a StreetInsider.com Premium Only Page

(DRMA) –

Apr 2, 2024 07:00 AM Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now

Mar 27, 2024 04:05 PM Dermata to Present at the Emerging Growth Conference on April 3, 2024

Mar 26, 2024 04:43 PM Form ARS Dermata Therapeutics, For: Dec 31

Mar 26, 2024 04:32 PM Form DEFA14A Dermata Therapeutics,

Mar 26, 2024 04:27 PM Form DEF 14A Dermata Therapeutics, For: Mar 05

Mar 21, 2024 04:06 PM Form 8-K Dermata Therapeutics, For: Mar 21

Mar 21, 2024 04:06 PM Form 10-K Dermata Therapeutics, For: Dec 31

Mar 21, 2024 04:05 PM Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results

Mar 4, 2024 06:03 AM Form PRE 14A Dermata Therapeutics, For: Feb 28

Feb 14, 2024 03:35 PM Form SC 13G Dermata Therapeutics, Filed by: ARMISTICE CAPITAL, LLC

Feb 6, 2024 07:00 AM Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now

Feb 1, 2024 09:00 AM Dermata to Present at the Emerging Growth Conference on February 7, 2024

Jan 12, 2024 04:06 PM Form 8-K Dermata Therapeutics, For: Jan 12

Jan 5, 2024 09:04 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Mento Steven J

Jan 5, 2024 09:03 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: FISHER MARY

Jan 5, 2024 09:03 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: PROEHL GERALD T

Jan 5, 2024 09:02 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Scott Kathleen D.

Jan 5, 2024 09:02 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Sandler Andrew Seth

Jan 5, 2024 09:02 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Nardo Christopher J.

Jan 5, 2024 09:01 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: HALE DAVID F

Jan 5, 2024 09:01 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Van Hoose Kyri K.

Jan 5, 2024 09:01 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: WIERENGA WENDELL

Jan 5, 2024 09:01 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Bradrick Brittany

Jan 5, 2024 09:01 PM Form 4 Dermata Therapeutics, For: Jan 04 Filed by: Bedoya-Toro Munera Maria E

Jan 4, 2024 04:07 PM Dermata Therapeutics (DRMA) Granted New Patent in Japan

Jan 4, 2024 04:05 PM Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis

Dec 20, 2023 04:05 PM Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

Dec 18, 2023 06:03 AM Form EFFECT Dermata Therapeutics,

Dec 15, 2023 05:01 PM Form 424B3 Dermata Therapeutics,

Dec 8, 2023 05:29 PM Form DEF 14A Dermata Therapeutics, For: Dec 07

Dec 7, 2023 04:07 PM Form S-3 Dermata Therapeutics,

Nov 29, 2023 05:16 PM Form PRE 14A Dermata Therapeutics, For: Nov 28

Nov 17, 2023 04:07 PM Form 8-K Dermata Therapeutics, For: Nov 16

Nov 16, 2023 01:34 PM Dermata Therapeutics (DRMA) Announces Exercise of Warrants for $2.26M in Gross Proceeds

Nov 16, 2023 08:00 AM Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols

Nov 16, 2023 06:08 AM Dermata Therapeutics, Inc (DRMA) Receives Nasdaq Non-compliance Notice

Nov 16, 2023 06:01 AM Form 8-K Dermata Therapeutics, For: Nov 15

Nov 16, 2023 12:00 AM Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Nov 9, 2023 04:10 PM Form 8-K Dermata Therapeutics, For: Nov 09

Nov 9, 2023 04:10 PM Form 10-Q Dermata Therapeutics, For: Sep 30

Nov 9, 2023 04:05 PM Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Sep 14, 2023 04:33 PM Form S-8 Dermata Therapeutics,

Aug 31, 2023 09:00 AM Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 31, 2023 09:00 AM Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 10, 2023 04:19 PM Form 8-K Dermata Therapeutics, For: Aug 10

Aug 10, 2023 04:17 PM Form 10-Q Dermata Therapeutics, For: Jun 30

Aug 10, 2023 04:15 PM Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

Aug 3, 2023 04:32 PM Form 8-K Dermata Therapeutics, For: Jul 28

Jul 28, 2023 06:06 AM Form EFFECT Dermata Therapeutics,

Jul 27, 2023 04:51 PM Form 424B4 Dermata Therapeutics,